US Patent Issued to Cell Signaling Technology on March 17 for "Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue" (Massachusetts Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,295, issued on March 17, was assigned to Cell Signaling Technology Inc. (Danvers, Mass.).

"Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue" was invented by Michael Comb (Manchester, Mass.), Ailan Guo (Lexington, Mass.), John Edward Rush II (Beverly, Mass.), Jun-Ming Cai (South Hamilton, Mass.), Jing Li (Brighton, Mass.) and Jing Zhou (Beverly, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is provided a motif-specific, context-independent antibody that specifically binds a recurring, modified motif consisting of (i) at least one sumoylated lysine residue, and (ii) one or...